Literature DB >> 19238460

Structure and localisation of drug binding sites on neurotransmitter transporters.

Aina W Ravna1, Ingebrigt Sylte, Svein G Dahl.   

Abstract

The dopamine (DAT), serotontin (SERT) and noradrenalin (NET) transporters are molecular targets for different classes of psychotropic drugs. The crystal structure of Aquifex aeolicus LeuT(Aa) was used as a template for molecular modeling of DAT, SERT and NET, and two putative drug binding sites (pocket 1 and 2) in each transporter were identified. Cocaine was docked into binding pocket 1 of DAT, corresponding to the leucine binding site in LeuT(Aa), which involved transmembrane helices (TMHs) 1, 3, 6 and 8. Clomipramine was docked into binding pocket 2 of DAT, involving TMHs 1, 3, 6, 10 and 11, and extracellular loops 4 and 6, corresponding to the clomipramine binding site in a crystal structure of a LeuT(Aa)-clomipramine complex. The structures of the proposed cocaine- and tricyclic antidepressant-binding sites may be of particular interest for the design of novel DAT interacting ligands.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19238460     DOI: 10.1007/s00894-009-0478-1

Source DB:  PubMed          Journal:  J Mol Model        ISSN: 0948-5023            Impact factor:   1.810


  39 in total

1.  Dopamine transporter tryptophan mutants highlight candidate dopamine- and cocaine-selective domains.

Authors:  Z Lin; W Wang; G R Uhl
Journal:  Mol Pharmacol       Date:  2000-12       Impact factor: 4.436

2.  Identification of a chloride ion binding site in Na+/Cl -dependent transporters.

Authors:  Lucy R Forrest; Sotiria Tavoulari; Yuan-Wei Zhang; Gary Rudnick; Barry Honig
Journal:  Proc Natl Acad Sci U S A       Date:  2007-07-24       Impact factor: 11.205

Review 3.  Three-dimensional models of neurotransmitter transporters and their interactions with cocaine and S-citalopram.

Authors:  Aina Westrheim Ravna
Journal:  World J Biol Psychiatry       Date:  2006       Impact factor: 4.132

Review 4.  The catecholamine hypothesis of affective disorders: a review of supporting evidence.

Authors:  J J Schildkraut
Journal:  Am J Psychiatry       Date:  1965-11       Impact factor: 18.112

5.  A comprehensive structure-based alignment of prokaryotic and eukaryotic neurotransmitter/Na+ symporters (NSS) aids in the use of the LeuT structure to probe NSS structure and function.

Authors:  Thijs Beuming; Lei Shi; Jonathan A Javitch; Harel Weinstein
Journal:  Mol Pharmacol       Date:  2006-07-31       Impact factor: 4.436

6.  Species-scanning mutagenesis of the serotonin transporter reveals residues essential in selective, high-affinity recognition of antidepressants.

Authors:  O V Mortensen; A S Kristensen; O Wiborg
Journal:  J Neurochem       Date:  2001-10       Impact factor: 5.372

7.  Antidepressant binding site in a bacterial homologue of neurotransmitter transporters.

Authors:  Satinder K Singh; Atsuko Yamashita; Eric Gouaux
Journal:  Nature       Date:  2007-08-08       Impact factor: 49.962

Review 8.  From membrane to molecule to the third amino acid from the left with a membrane transport protein.

Authors:  H R Kaback; J Wu
Journal:  Q Rev Biophys       Date:  1997-11       Impact factor: 5.318

9.  High affinity recognition of serotonin transporter antagonists defined by species-scanning mutagenesis. An aromatic residue in transmembrane domain I dictates species-selective recognition of citalopram and mazindol.

Authors:  E L Barker; M A Perlman; E M Adkins; W J Houlihan; Z B Pristupa; H B Niznik; R D Blakely
Journal:  J Biol Chem       Date:  1998-07-31       Impact factor: 5.157

10.  The distribution of positively charged residues in bacterial inner membrane proteins correlates with the trans-membrane topology.

Authors:  G Heijne
Journal:  EMBO J       Date:  1986-11       Impact factor: 11.598

View more
  16 in total

1.  Molecular mechanism of serotonin transporter inhibition elucidated by a new flexible docking protocol.

Authors:  Mari Gabrielsen; Rafał Kurczab; Aina W Ravna; Irina Kufareva; Ruben Abagyan; Zdzisław Chilmonczyk; Andrzej J Bojarski; Ingebrigt Sylte
Journal:  Eur J Med Chem       Date:  2011-10-20       Impact factor: 6.514

2.  Characterization of [³H]CFT binding to the norepinephrine transporter suggests that binding of CFT and nisoxetine is not mutually exclusive.

Authors:  Juan Zhen; Solav Ali; Aloke K Dutta; Maarten E A Reith
Journal:  J Neurosci Methods       Date:  2011-09-12       Impact factor: 2.390

3.  Structure-activity relationships for a novel series of citalopram (1-(3-(dimethylamino)propyl)-1-(4-fluorophenyl)-1,3-dihydroisobenzofuran-5-carbonitrile) analogues at monoamine transporters.

Authors:  Peng Zhang; George Cyriac; Theresa Kopajtic; Yongfang Zhao; Jonathan A Javitch; Jonathan L Katz; Amy Hauck Newman
Journal:  J Med Chem       Date:  2010-08-26       Impact factor: 7.446

Review 4.  Monoamine transporter structure, function, dynamics, and drug discovery: a computational perspective.

Authors:  Sankar Manepalli; Christopher K Surratt; Jeffry D Madura; Tammy L Nolan
Journal:  AAPS J       Date:  2012-08-24       Impact factor: 4.009

5.  Site-directed mutations near transmembrane domain 1 alter conformation and function of norepinephrine and dopamine transporters.

Authors:  Bipasha Guptaroy; Rheaclare Fraser; Aalisha Desai; Minjia Zhang; Margaret E Gnegy
Journal:  Mol Pharmacol       Date:  2010-12-13       Impact factor: 4.436

6.  Clomipramine-induced serum prolactin as a marker for serotonin and dopamine turnover: results of an open label study.

Authors:  Joachim Cordes; Kai G Kahl; Christian Werner; Uwe Henning; Gunnar Regenbrecht; Rolf Larisch; Christian Schmidt-Kraepelin; Johanna Thünker; Marcus W Agelink; Stefan Löffler; Thomas Hohlfeld; Wolfgang Gaebel; Ansgar Klimke
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2011-03-15       Impact factor: 5.270

7.  Molecular dynamics simulation of oseltamivir resistance in neuraminidase of avian influenza H5N1 virus.

Authors:  Mao Shu; Zhihua Lin; Yunru Zhang; Yuqian Wu; Hu Mei; Yongjun Jiang
Journal:  J Mol Model       Date:  2010-06-03       Impact factor: 1.810

8.  Comparative modeling of the human monoamine transporters: similarities in substrate binding.

Authors:  Heidi Koldsø; Anja B Christiansen; Steffen Sinning; Birgit Schiøtt
Journal:  ACS Chem Neurosci       Date:  2012-11-08       Impact factor: 4.418

9.  GABA transporter lysine 448: a key residue for tricyclic antidepressants interaction.

Authors:  Francesca Cherubino; Andreea Miszner; Maria Daniela Renna; Rachele Sangaletti; Stefano Giovannardi; Elena Bossi
Journal:  Cell Mol Life Sci       Date:  2009-12       Impact factor: 9.261

10.  Antidepressant specificity of serotonin transporter suggested by three LeuT-SSRI structures.

Authors:  Zheng Zhou; Juan Zhen; Nathan K Karpowich; Christopher J Law; Maarten E A Reith; Da-Neng Wang
Journal:  Nat Struct Mol Biol       Date:  2009-05-10       Impact factor: 15.369

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.